Our Guest: Chris Bahl, Co-Founder, President & Chief Scientific Officer at AI ProteinsWhat you'll get out of this episode:Bahl's backgroundOverview of AI ProteinsHow they are utilizing computational protein design to engineer synthetic miniproteins therapeutics that can bind to any targetThe process and challengesKey differentiatorsTheir impact on the future of medicineOur sponsors for this episode are Sage Growth PartnersSage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media - @sagegrowthpartners

Ver todos los episodios